Research Report on China's Venlafaxine Market, 2021-2025
SKU ID :CRI-19159377 | Published Date: 16-Sep-2021 | No. of pages: 40Description
TOC
Table of Contents
1 Relevant Concept of Venlafaxine
1.1 Indications of Venlafaxine
1.2 Development of China’s Venlafaxine Market
1.3 Governmental Approval of Venlafaxine in China
1.4 The Impact of COVID-19 on China’s Venlafaxine Market
2 Sales of Venlafaxine in China, 2016-2020
2.1 Sales Value
2.1.1 Sales Value in China
2.1.2 Sales Value in China by Region
2.2 Sales Volume
2.2.1 Sales Volume in China
2.2.2 Sales Volume in China by Region
2.3 Sales of Venlafaxine in China by Dosage Form, 2016-2020
2.3.1 Extended-Release Capsules
2.3.2 Extended-Release Tablets
2.3.3 Capsules
2.3.4 Other Dosage Forms
3 Analysis of Major Venlafaxine Manufacturers in China, 2020
3.1 Analysis of Market Share
3.1.1 Market Share of Manufacturers by Sales Value
3.1.2 Market Share of Manufacturers by Sales Volume
3.2 Pfizer Healthcare Ireland
3.2.1 Company Profile
3.2.2 Sales of Venlafaxine in China
3.3 Chengdu Kanghong Pharmaceutical Group
3.3.1 Company Profile
3.3.2 Sales of Venlafaxine in China
3.4 Beijing Winsunny Pharmaceutical Co., Ltd
3.5 Chengdu Beite Pharmaceutical Co., Ltd
3.6 Guizhou Salvage Pharmaceutical Co., Ltd
4 Sales Price of Venlafaxine of Different Companies in China, 2020-2021
4.1 Pfizer Healthcare Ireland (Effexor XR®)
4.2 Chengdu Kanghong Pharmaceutical Group (Bolexin®)
4.3 Beijing Winsunny Pharmaceutical Co., Ltd (WenYueSi®)
4.4 Chengdu Beite Pharmaceutical Co., Ltd (BeiTe®)
4.5 Guizhou Salvage Pharmaceutical Co., Ltd (ShengJiLe®)
5 Prospects of China’s Venlafaxine Market, 2021-2025
5.1 Influencing Factors for the Market Development
5.1.1 The Impact of COVID-19 on the Market
5.1.2 Market Drivers and Opportunities
5.1.3 Market Threats and Challenges
5.2 Forecast on Market Size
5.3 Forecast on Market Trend
List of Charts
Chart Patent Information of Venlafaxine in China
Chart Sales Value of Venlafaxine in China, 2016-2020
Chart Sales Volume of Venlafaxine in China, 2016-2020
Chart Sales Volume of Venlafaxine in China by Region, 2016-2020
Chart Sales Value of Venlafaxine in China by Region, 2016-2020
Chart Sales Volume of Venlafaxine Extended-Release Capsules in China, 2016-2020
Chart Sales Volume of Venlafaxine Extended-Release Tablets in China, 2016-2020
Chart Sales Volume of Venlafaxine Tablets in China, 2016-2020
Chart Market Share of Venlafaxine Manufacturers in China by Sales Value, 2016-2020
Chart Sales Value and Volume of Venlafaxine (of Pfizer Healthcare Ireland) in China, 2016-2020
Chart Sales Value and Volume of (Venlafaxine of Chengdu Kanghong Pharmaceutical Group) in China, 2016-2020
Chart Sales Price of Effexor XR (Venlafaxine of Pfizer Healthcare Ireland) in China, 2016-2020
Chart Sales Price of Bolexin (Venlafaxine of Chengdu Kanghong Pharmaceutical Group) in China, 2016-2020
Chart Forecast on Sales Value of Venlafaxine in China, 2021-2025
Chart Forecast on Sales Volume of Venlafaxine in China, 2021-2025
Tables & Figures
Companies
1 Pfizer Healthcare Ireland (Effexor XR®)
2 Chengdu Kanghong Pharmaceutical Group (Bolexin®)
3 Beijing Winsunny Pharmaceutical Co., Ltd (WenYueSi®)
4 Chengdu Beite Pharmaceutical Co., Ltd (BeiTe®)
5 Guizhou Salvage Pharmaceutical Co., Ltd (ShengJiLe®)
- PRICE
-
$2600$3900